{"rows":[{"id":5749,"title":"Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex","authors":"Wawrzczak-Bargieła Agnieszka, Jelonek-Kozioł Małgorzata, Kumorek Weronika, Bilecki Wiktor, Maćkowiak Marzena","journal":"Psychopharmacology","publication_date":"2026-07-28","publication_year":2026,"doi":"10.1007/s00213-026-07132-6","pubmed_id":"42517891","openalex_id":"https://openalex.org/W7171554840","source_url":"https://doi.org/10.1007/s00213-026-07132-6","substance_tags":"psilocybin","topic_tags":"Epigenetics,Animal Study","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-29 01:20:04","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42517891","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1007/s00213-026-07132-6","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42517891","source_url":"https://doi.org/10.1007/s00213-026-07132-6","doi":"10.1007/s00213-026-07132-6","pmid":"42517891","publication_date":"2026-07-28","importer_version":"2.1.3","text_redistributed":false}},{"id":3811,"title":"Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.","authors":"Smith SA, Mohammad H, Lee LHN, Dennett L, Smith S, Burback L, Winkler O, Greenshaw A, Jetly R, Kennedy SH, Bhat V, Swainson J, Vermetten E, Cao B, Li XM, Zhang Y","journal":"Psychopharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1007/s00213-026-07110-y","pubmed_id":"42380668","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42380668/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Emotional Processing,Review Article","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 13:00:05","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:42380668","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42380668/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42380668","source_url":"https://pubmed.ncbi.nlm.nih.gov/42380668/","doi":"10.1007/s00213-026-07110-y","pmid":"42380668","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":475,"title":"Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days.","authors":"St Pierre M, Argento E, Cates J, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Paschall SA, Kuypers KPC, Rootman J, Walsh Z","journal":"Psychopharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1007/s00213-025-06913-9","pubmed_id":"41073618","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41073618/","substance_tags":"psilocybin","topic_tags":"Microdosing,Observational Study","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:41073618","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41073618/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41073618","source_url":"https://pubmed.ncbi.nlm.nih.gov/41073618/","doi":"10.1007/s00213-025-06913-9","pmid":"41073618","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":468,"title":"Provider perspectives on challenges in treatment during psychedelic therapy.","authors":"Bender DA, Nayak SM, Siegel JS, Hellerstein DJ, Ercal BC, Lenze EJ","journal":"Psychopharmacology","publication_date":"2026-07-01","publication_year":2026,"doi":"10.1007/s00213-025-06907-7","pubmed_id":"41139739","openalex_id":"https://openalex.org/W4415564957","source_url":"https://pubmed.ncbi.nlm.nih.gov/41139739/","substance_tags":"psilocybin","topic_tags":"PTSD,Aging,Clinical Trial,Review Article,Observational Study,Adverse Events","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:46","bibtex":null,"source_record_id":"PMID:41139739","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41139739/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41139739","source_url":"https://pubmed.ncbi.nlm.nih.gov/41139739/","doi":"10.1007/s00213-025-06907-7","pmid":"41139739","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":97,"title":"Psilocybin-induced neurocardiogenic syncope: a case report","authors":"Atiq Mazen A., Weisman Eli, Guerra Rodrigo B., Martinez Luis Luna, Yaden David B., Barrett Frederick S., Nayak Sandeep, Sayali Ceyda","journal":"Psychopharmacology","publication_date":"2026-05-28","publication_year":2026,"doi":"10.1007/s00213-026-07079-8","pubmed_id":"42207275","openalex_id":"https://openalex.org/W7162662445","source_url":"https://doi.org/10.1007/s00213-026-07079-8","substance_tags":"psilocybin","topic_tags":"Anxiety,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:47","bibtex":null,"source_record_id":"PMID:42207275","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1007/s00213-026-07079-8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42207275","source_url":"https://doi.org/10.1007/s00213-026-07079-8","doi":"10.1007/s00213-026-07079-8","pmid":"42207275","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}},{"id":4027,"title":"Evaluating the evidence for repressed memory recovery in psychedelic contexts","authors":"Anne-Fiona Griesfeller, Lotte Kooman, Lilian Kloft-Heller, Samuli Kangaslampi, Johannes G Ramaekers, Henry Otgaar","journal":"Psychopharmacology","publication_date":"2026-04-28","publication_year":2026,"doi":"10.1007/s00213-026-07076-x","pubmed_id":"42053657","openalex_id":"https://openalex.org/W7158128609","source_url":"https://doi.org/10.1007/s00213-026-07076-x","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Consciousness,Review Article,Toxicity","study_type":"Review Article","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:35","last_checked":"2026-07-04 06:34:35","bibtex":null,"source_record_id":"PMID:42053657","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s00213-026-07076-x","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:42053657","source_url":"https://doi.org/10.1007/s00213-026-07076-x","doi":"10.1007/s00213-026-07076-x","pmid":"42053657","publication_date":"2026-04-28","importer_version":"2.1.3","text_redistributed":false}},{"id":3713,"title":"Psychedelics and autobiographical memory - six open questions.","authors":"Kangaslampi S, Lietz M","journal":"Psychopharmacology","publication_date":"2025-10-01","publication_year":2025,"doi":"10.1007/s00213-025-06771-5","pubmed_id":"40095090","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40095090/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 11:08:40","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40095090","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40095090/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40095090","source_url":"https://pubmed.ncbi.nlm.nih.gov/40095090/","doi":"10.1007/s00213-025-06771-5","pmid":"40095090","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":500,"title":"Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.","authors":"Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD","journal":"Psychopharmacology","publication_date":"2025-10-01","publication_year":2025,"doi":"10.1007/s00213-025-06788-w","pubmed_id":"40266291","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40266291/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40266291","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40266291/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40266291","source_url":"https://pubmed.ncbi.nlm.nih.gov/40266291/","doi":"10.1007/s00213-025-06788-w","pmid":"40266291","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":499,"title":"Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice.","authors":"McGriff SA, Hecker JC, Maitland AD, Partilla JS, Baumann MH, Glatfelter GC","journal":"Psychopharmacology","publication_date":"2025-10-01","publication_year":2025,"doi":"10.1007/s00213-025-06795-x","pubmed_id":"40381003","openalex_id":"https://openalex.org/W4410466765","source_url":"https://pubmed.ncbi.nlm.nih.gov/40381003/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study,Drug Interactions","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40381003","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40381003/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40381003","source_url":"https://pubmed.ncbi.nlm.nih.gov/40381003/","doi":"10.1007/s00213-025-06795-x","pmid":"40381003","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":498,"title":"Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.","authors":"Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD","journal":"Psychopharmacology","publication_date":"2025-10-01","publication_year":2025,"doi":"10.1007/s00213-025-06818-7","pubmed_id":"40381005","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40381005/","substance_tags":"psilocybin","topic_tags":"Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:40381005","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40381005","source_url":"https://pubmed.ncbi.nlm.nih.gov/40381005/","doi":"10.1007/s00213-025-06818-7","pmid":"40381005","publication_date":"2025-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4315,"title":"Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality","authors":"Jussi Jylkkä, Aila Mustamo","journal":"Psychopharmacology","publication_date":"2025-08-10","publication_year":2025,"doi":"10.1007/s00213-025-06871-2","pubmed_id":"40788485","openalex_id":"https://openalex.org/W4413101529","source_url":"https://doi.org/10.1007/s00213-025-06871-2","substance_tags":"psilocybin","topic_tags":"Wellbeing,Spirituality,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:39","last_checked":"2026-07-04 06:34:39","bibtex":null,"source_record_id":"PMID:40788485","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s00213-025-06871-2","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"PMID:40788485","source_url":"https://doi.org/10.1007/s00213-025-06871-2","doi":"10.1007/s00213-025-06871-2","pmid":"40788485","publication_date":"2025-08-10","importer_version":"2.1.3","text_redistributed":false}},{"id":592,"title":"Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.","authors":"Ley L, Liechti ME, Becker AM, Straumann I, Klaiber A, Holze F, Vogt SB, Arikci D, Schmid Y","journal":"Psychopharmacology","publication_date":"2025-08-01","publication_year":2025,"doi":"10.1007/s00213-025-06772-4","pubmed_id":"40140019","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/40140019/","substance_tags":"psilocybin","topic_tags":"Healthy Volunteers","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:57","bibtex":null,"source_record_id":"PMID:40140019","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40140019/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40140019","source_url":"https://pubmed.ncbi.nlm.nih.gov/40140019/","doi":"10.1007/s00213-025-06772-4","pmid":"40140019","publication_date":"2025-08-01","importer_version":"2.1.3","text_redistributed":false}},{"id":642,"title":"Effects of psilocybin, the 5-HT receptor agonist TCB-2, and the 5-HT receptor antagonist M100907 on visual attention in male mice in the continuous performance test.","authors":"Rahbarnia A, Li Z, Fletcher PJ","journal":"Psychopharmacology","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1007/s00213-023-06474-9","pubmed_id":"37855864","openalex_id":"https://openalex.org/W4387764874","source_url":"https://pubmed.ncbi.nlm.nih.gov/37855864/","substance_tags":"psilocybin","topic_tags":"Depression,Receptor Pharmacology,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:37855864","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37855864/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37855864","source_url":"https://pubmed.ncbi.nlm.nih.gov/37855864/","doi":"10.1007/s00213-023-06474-9","pmid":"37855864","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":640,"title":"Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.","authors":"Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS","journal":"Psychopharmacology","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1007/s00213-024-06599-5","pubmed_id":"38743110","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/38743110/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:38743110","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38743110/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38743110","source_url":"https://pubmed.ncbi.nlm.nih.gov/38743110/","doi":"10.1007/s00213-024-06599-5","pmid":"38743110","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":638,"title":"Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.","authors":"Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A","journal":"Psychopharmacology","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1007/s00213-024-06644-3","pubmed_id":"38963553","openalex_id":"https://openalex.org/W4400335852","source_url":"https://pubmed.ncbi.nlm.nih.gov/38963553/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Mechanism of Action,Animal Study,Treatment-Resistant Depression,Drug Interactions","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:38963553","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38963553/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38963553","source_url":"https://pubmed.ncbi.nlm.nih.gov/38963553/","doi":"10.1007/s00213-024-06644-3","pmid":"38963553","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":685,"title":"Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.","authors":"Kolasa M, Nikiforuk A, Korlatowicz A, Solich J, Potasiewicz A, Dziedzicka-Wasylewska M, Bugno R, Hogendorf A, Bojarski A, Faron-Górecka A","journal":"Psychopharmacology","publication_date":"2025-06-01","publication_year":2025,"doi":"10.1007/s00213-024-06654-1","pubmed_id":"39030424","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39030424/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Animal Study,Treatment-Resistant Depression","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:39030424","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39030424","source_url":"https://pubmed.ncbi.nlm.nih.gov/39030424/","doi":"10.1007/s00213-024-06654-1","pmid":"39030424","publication_date":"2025-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":683,"title":"Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.","authors":"Yousefi P, Lietz MP, O'Higgins FJ, Rippe RCA, Hasler G, van Elk M, Enriquez-Geppert S","journal":"Psychopharmacology","publication_date":"2025-06-01","publication_year":2025,"doi":"10.1007/s00213-024-06742-2","pubmed_id":"39847068","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39847068/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Meta-Analysis,Systematic Review,Review Article,Healthy Volunteers","study_type":"Meta-Analysis","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:59","bibtex":null,"source_record_id":"PMID:39847068","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39847068/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39847068","source_url":"https://pubmed.ncbi.nlm.nih.gov/39847068/","doi":"10.1007/s00213-024-06742-2","pmid":"39847068","publication_date":"2025-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":760,"title":"Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation.","authors":"Irrmischer M, Puxty D, Yıldırım BO, Deijen JB, Engelbregt H","journal":"Psychopharmacology","publication_date":"2025-04-01","publication_year":2025,"doi":"10.1007/s00213-024-06733-3","pubmed_id":"39775022","openalex_id":"https://openalex.org/W4406141686","source_url":"https://pubmed.ncbi.nlm.nih.gov/39775022/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Personality Change,Emotional Processing,Mystical Experience","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:00","bibtex":null,"source_record_id":"PMID:39775022","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39775022/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39775022","source_url":"https://pubmed.ncbi.nlm.nih.gov/39775022/","doi":"10.1007/s00213-024-06733-3","pmid":"39775022","publication_date":"2025-04-01","importer_version":"2.1.3","text_redistributed":false}},{"id":909,"title":"Practical considerations in the establishment of psychedelic research programs.","authors":"Barnett BS, Vest MF, Delatte MS, King Iv F, Mauney EE, Coulson AJ, Nayak SM, Hendricks PS, Greer GR, Murnane KS","journal":"Psychopharmacology","publication_date":"2025-01-01","publication_year":2025,"doi":"10.1007/s00213-024-06722-6","pubmed_id":"39627438","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/39627438/","substance_tags":"psilocybin","topic_tags":"Aging,Clinical Trial,Review Article","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:28:05","bibtex":null,"source_record_id":"PMID:39627438","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/39627438/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:39627438","source_url":"https://pubmed.ncbi.nlm.nih.gov/39627438/","doi":"10.1007/s00213-024-06722-6","pmid":"39627438","publication_date":"2025-01-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1067,"title":"Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.","authors":"Sakai K, Bradley ER, Zamaria JA, Agin-Liebes G, Kelley DP, Fish A, Martini V, Ferris MC, Morton E, Michalak EE, O'Donovan A, Woolley JD","journal":"Psychopharmacology","publication_date":"2024-08-01","publication_year":2024,"doi":"10.1007/s00213-024-06585-x","pubmed_id":"38687360","openalex_id":"https://openalex.org/W4396518351","source_url":"https://pubmed.ncbi.nlm.nih.gov/38687360/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Safety,Toxicity,Drug Interactions","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:07","bibtex":null,"source_record_id":"PMID:38687360","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38687360/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38687360","source_url":"https://pubmed.ncbi.nlm.nih.gov/38687360/","doi":"10.1007/s00213-024-06585-x","pmid":"38687360","publication_date":"2024-08-01","importer_version":"2.1.3","text_redistributed":false}}],"total":85,"page":1,"per_page":20,"pages":5,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Psychopharmacology","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}